Business Wire

Creative Artists Agency Names Steve Hasker CEO of CAA Global

Del

Leading entertainment and sports agency, Creative Artists Agency (CAA), announced today that industry veteran Steve Hasker has been appointed CEO of the recently structured CAA Global. He will manage the intersection between CAA's market-leading representation business and its high-growth businesses and investments, bringing together the agency's growth platforms and ongoing strategic initiatives. He will also join CAA's board of directors, and oversee the company's strategic planning, mergers and acquisitions, principal investing, and corporate development initiatives, as well as the company's data strategy.

Hasker most recently served as Global President and Chief Operating Officer of Nielsen Holdings PLC, where he oversaw all of Nielsen’s commercial, data, and product-related activities for both the media and consumer businesses. He joins CAA in January, 2018.

“CAA Global is an exciting step in the continued growth and diversification of CAA,” said agency President Richard Lovett. “Steve is a transformational and highly accomplished industry executive, and we are thrilled, after conducting an extensive search, to have found someone who also shares so profoundly our cultural priority of collaborative success. Under Steve’s leadership, we are confident that CAA Global will capitalize on the strength of CAA’s position at the nexus of talent, content, technology, and brands across the global marketplace to accelerate growth and innovation for CAA and our clients.”

CAA Global includes assets such as CAA China, a joint venture with CMC Capital Partners that builds upon CAA’s 12 years of success in the fast-growing market; Evolution Media, CAA’s merchant bank, founded in 2008, that has advised on billions of dollars in mergers and acquisitions and manages a $500 million media, technology and consumer brand investment vehicle; CAA Ventures, an early-stage venture capital fund with 45 portfolio companies; and Vancouver-based Creative Labs, which builds consumer-facing technology companies and next-generation media and entertainment experiences.

“CAA is very well positioned to take advantage of massive technology disruption and changing consumer behavior,” said Hasker. “I look forward to building upon CAA’s long history of industry leadership and relentless innovation to create successful new global businesses and opportunities for its clients and the company.”

CAA has long been recognized for its unmatched roster of the world’s premier artists, athletes, and blue-chip brands, as well as its category leadership in packaging television and film content and live experiences. CAA was also the first agency to build a sports business, create an investment bank, launch a venture fund, found technology start-up companies, establish a presence in China, and start a successful private equity vehicle, among other industry advances.

“CAA’s management team has demonstrated its ability to help drive the evolution of the media and entertainment industry. Since our initial investment in CAA, the company has continued to expand and diversify to capture its enormous potential,” said James Coulter, co-founder of global investment firm TPG, CAA’s majority shareholder. “CAA Global exemplifies these successful efforts, and with Steve as its CEO, we have a deeply experienced business leader with a proven ability to drive growth. We’re confident CAA will continue to accomplish exciting things.”

Prior to joining Nielsen in 2009, Hasker served as a partner in McKinsey & Company’s Global Media, Entertainment and Information practice, focused on strategy, growth, and innovation in television, data, filmed entertainment, sports, and digital advertising. Before joining McKinsey, Hasker served in a number of financial roles in the U.S., Russia and Australia.

A lecturer at Columbia University and New York University, Hasker’s research has been published in the Harvard Business Review. He graduated from the University of Melbourne and earned his MBA and Masters in International Affairs, both with honors, from Columbia University.

About Creative Artists Agency

Leading entertainment and sports agency Creative Artists Agency (CAA) represents many of the most successful professionals working in film, television, music, theatre, video games, sports, and digital content, and provides a range of strategic marketing and consulting services to corporate clients. CAA is a leader in sports, representing more than 1,000 of the world’s top athletes in football, baseball, basketball, hockey, soccer, tennis, and golf, and works in the areas of broadcast rights, corporate marketing initiatives, licensing, and sports properties for sales and sponsorship opportunities.

Contact information

Creative Artists Agency (CAA)
Beth McClinton, 424.288.2247
Beth.McClinton@caa.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Pierre Fabre & Array BioPharma Announce a 62% Observed OS at One Year from the Phase 3 BEACON CRC Safety Lead-In of the Combination of Encorafenib, Binimetinib and Cetuximab in BRAF-Mutant CRC at the ESMO GI Congress23.6.2018 11:00Pressemelding

Not intended for UK- and US-based media Pierre Fabre and its partner Array BioPharma Inc. today announced updated safety and efficacy results, including OS, from the safety lead-in of the Phase 3 BEACON CRC trial evaluating the triplet combination of encorafenib, a BRAF inhibitor, binimetinib, a MEK inhibitor and cetuximab, an anti-EGFR antibody, in patients with BRAF V600E -mutant metastatic colorectal cancer (CRC). The results showed that, at the time of analysis, the OS data were fully mature through 12.6 months and that the median OS had not yet been reached. The one-year overall survival rate for this cohort was 62%. These data were presented in an oral presentation on Saturday, June 23, at the ESMO 20th World Congress on Gastrointestinal Cancer in Barcelona, Spain. The median progression-free survival (mPFS) for patients treated with the triplet was 8 months [95% CI 5.6-9.3] and is similar between patients receiving one prior line of therapy and patients receiving two prior lines

Compelling Data for LONSURF® (trifluridine/tipiracil) in Metastatic Colorectal Cancer Presented at ESMO’s World Congress on Gastrointestinal Cancer by Servier and Taiho23.6.2018 08:10Pressemelding

Servier and Taiho Pharmaceutical Co., Ltd. today announced that the TASCO-1 trial demonstrated promising results for LONSURF® (trifluridine/tipiracil) in combination with bevacizumab in patients with previously untreated metastatic colorectal cancer (mCRC) who are not suitable for intensive treatment, with a median progression-free survival (PFS) of 9.2 months (ranging from 7.6 to 11.5 months). A second non-comparative arm in the trial, evaluated the outcome of patients treated with the current standard of care of capecitabine in combination with bevacizumab. The median PFS of this arm was 7.8 months (ranging from 5.5 to 10.1 months). “Colorectal cancer is the third most common cancer in the world. While there has been some progress in treatment, there are still few options for patients with metastatic disease who are not suitable for intensive treatment,” said Professor Eric Van Cutsem, Head of Digestive Oncology at the University of Leuven, Belgium. “These compelling results suggest

Softomotive and Accelerate RPA Partner to Help Enterprises Achieve Faster Time to Value from RPA22.6.2018 15:13Pressemelding

Softomotive, a world–class Robotic Process Automation (RPA) technology provider offering best time to value and affordability for all sizes and types of enterprises, is pleased to announce a strategic partnership with AccelerateRPA, a high calibre professional services provider of trained and certified RPA Consultants within Robotic Process Automation. This partnership means that customers and end users of Softomotive’s software, will have additional knowledgeable and professional guidance available to help achieve significant value quickly from their investment in RPA. Companies who are looking to implement Softomotive’s RPA product suite (WinAutomation and ProcessRobot software) will now have direct access to AccelerateRPA’s highly skilled consultants and Developers. Further, AccelerateRPA has also become a licensed reseller of Softomotive’s products, offering customers a single point of contact for delivering both RPA software and services. Ashley Hudson, Director of AccelerateRPA,

Ascend Performance Materials Announces Price Increase for Intermediate Materials22.6.2018 14:00Pressemelding

Ascend Performance Materials announced today a price increase for its intermediate materials. The price increase will take effect globally on July 1, 2018, and includes the following terms: Material Price Increase Terms Hexamethylene diamine (HMD) $0.17/lb. • As contracts allow. • Non-contract business – price determined on an order-by-order basis. Acrylonitrile (AN) $0.20/lb. • As contracts allow. • Non-contract business – price determined on an order-by-order basis. Customers should contact their local sales representative for additional information. About Ascend Performance Materials Ascend Performance Materials is a global premium provider of high-quality plastics, fibers and chemicals and is the world’s largest integrated producer of PA66 resin. Headquartered in Houston, Texas, Ascend has eight global locations, including five fully-integrated manufacturing facilities located in the southeastern United States, all dedicated to the innovation and safe production of nylon 6,6. With

Different Countries, Different Customs: Get Ready for the Motorbike Holidays with Moto-tyres.co.uk22.6.2018 13:41Pressemelding

Pack your bags, close the boot and get away on holiday? When you start your holidays on a motorcycle, you usually have to consider a few things more when getting ready for your trip. The right preparation is therefore a must. So that nothing stands in the way of a smooth journey, Moto-tyres.co.uk has put together some tips for your next trip. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180622005345/en/ Different countries, different customs: get ready for the motorbike holidays with Moto-tyres.co.uk (Photo: Business Wire) Whether a weekend trip or extended adventure, it all depends on the right equipment. Functional clothing, protectors and rain protection are a must on long trips. Wearing a suitable motorcycle helmet is a legal requirement almost everywhere. However, there are also very different rules and regulations for motorbike equipment and accessories depending on the destination, and you should familiarise yoursel

Boehringer Ingelheim bolsters biologics research and development with 230 million euro investment in new development center22.6.2018 12:00Pressemelding

Today Boehringer Ingelheim announced a 230 million euro investment into a new Biologicals Development Center (BDC) at the company’s Research and Development site in Biberach, Germany during the foundation stone laying for the new center. “The BDC is another key building block supporting the company’s long-term strategy for increasing the pipeline’s share of biologicals. This is particularly driven by two of our core areas, immune oncology and immunology,” says Dr. Fridtjof Traulsen, Corporate Senior Vice President Development at Boehringer Ingelheim. “The share of new biological entities in Boehringer Ingelheim’s research pipeline has been consistently increasing over the past few years and has now reached forty percent.” The BDC will help to maximize synergies by integrating biologicals analytical and process development as well as manufacturing for clinical studies into one seamless unit, while at the same time increasing development capacity. Following a staggered launch beginning i